Neorich Biopharma Tech Co Ltd (PHBID) Stock Price, Trades & News

Pharmagreen Biotech Inc is a biotech science company with specialized products and services in the cannabis industry. The company plans to produce and sell tissue culture plantlets and cannabis oil. Its line of nutraceutical products is a proprietary blend of therapeutic plants and mushrooms. It is developing its business model beyond just cannabis, and is focused on near term revenues from its proprietary blend of therapeutic plants and fungi, a nutraceutical wellness product. Utilizing the Company's expertise in plant genetics, Its transgenic program uses the newest technology available to research and create nutraceuticals, protein-based vaccines, and daily supplements with the potential to improve lives and address a wide variety of disease conditions.

Financial Strength

	Name	Current	Vs Industry		Vs History

Growth Rank

	Name	Current	Vs Industry		Vs History

Momentum Rank

	Name	Current	Vs Industry		Vs History
	5-Day RSI	12.82
	9-Day RSI	19.19
	14-Day RSI	24.23
	3-1 Month Momentum %	-52.63
	6-1 Month Momentum %	-52.63

Liquidity Ratio

	Name	Current	Vs Industry		Vs History

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History

Profitability Rank

	Name	Current	Vs Industry		Vs History
	FCF Margin %	-6850
	OCF Margin %	-6850

GF Value Rank

	Name	Current	Vs Industry		Vs History

Financials (Next Earnings Date:2026-11-07 Est.)

Annual Quarterly TTM

PHBID's 30-Y Financials

AAPL

Income Statement Breakdown FY

Annual Quarterly

Not Enough Data

AAPL

Balance Sheet Breakdown

Annual Quarterly

Not Enough Data

AAPL

Cashflow Statement Breakdown

Annual Quarterly

Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Value % YoY

Historical Operating Revenue by Geographic Region

Value % YoY

See Details

5-Step DuPont Analysis as of

Annual Quarterly

Not Enough Data

Guru Trades

See Details

Insider Trades

See Details

Gurus Latest Trades with OTCPK:PHBID

No Available Data

Peter Lynch Chart

Y-axis scale:

Log Linear

Interactive Chart

Performance

Dividend

Log

Bar

Annualized Return %

Symbol	1 Week	1 Month	3 Months	6 Months	YTD	1 Year	3 Years	5 Years	10 Years

Total Annual Return %

Symbol	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017

Neorich Biopharma Tech Co Ltd Executives

Details

GF Value™

PHBID

Valuation Chart

Year:

Warning Signs

Warning! GuruFocus detected issues with PHBID. Try a 7-Day Free Trial to check it out.

Analyst Estimate

Annual Quarterly

Key Statistics

	Name	Value
	Revenue (TTM) (Mil $)	0.002
	EPS (TTM) ($)	-
	Beta	2.5384
	3-Year Sharpe Ratio	0.44
	3-Year Sortino Ratio	1.46
	Volatility %	94.44
	14-Day RSI	24.23
	14-Day ATR ($)	0.317281
	20-Day SMA ($)	1.685
	12-1 Month Momentum %	-
	52-Week Range ($)	0.6 - 7
	Shares Outstanding (Mil)	0.35

Piotroski F-Score Details

Year:

	Component	Result
	Piotroski F-Score	0
	Positive ROA
	Positive CFROA
	Higher ROA yoy
	CFROA > ROA
	Lower Leverage yoy
	Higher Current Ratio yoy
	Less Shares Outstanding yoy
	Higher Gross Margin yoy
	Higher Asset Turnover yoy

Neorich Biopharma Tech Co Ltd Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

Neorich Biopharma Tech Co Ltd Stock Events

Financials Calendars

Event	Date	Price ($)
Annual report for 2026	2026-11-26	In 105 days
0.0005:1 Stock Split	2026-08-12	1.00 (-16.67%)
Third quarter earnings results for 2026	2026-08-07	1.80 (+0.00%)
Second quarter earnings results for 2026	2026-05-15	3.40 (+17.24%)
First quarter earnings results for 2026	2026-02-23	3.80 (+0.00%)
Annual report for 2025	2025-11-26	3.40 (+0.00%)
Third quarter earnings results for 2025	2025-08-01	1.72 (-4.44%)
Second quarter earnings results for 2025	2025-05-13	2.00 (+0.00%)
First quarter earnings results for 2025	2025-02-12	3.50 (+2.94%)
Annual report for 2024	2024-12-10	3.20 (+0.00%)

Show

Entries

Neorich Biopharma Tech Co Ltd Frequently Asked Questions

What is Neorich Biopharma Tech Co Ltd(PHBID)'s stock price today?

The current price of PHBID is $1.00. The 52 week high of PHBID is $7.00 and 52 week low is $0.60.

When is next earnings date of Neorich Biopharma Tech Co Ltd(PHBID)?

The next earnings date of Neorich Biopharma Tech Co Ltd(PHBID) is 2026-11-07 Est..

Does Neorich Biopharma Tech Co Ltd(PHBID) pay dividends? If so, how much?

Neorich Biopharma Tech Co Ltd(PHBID) does not pay dividend.

Guru Commentaries on OTCPK:PHBID

No articles.

Press Release

	Subject	Date
	PHBI - Pharmagreen Signs Supply Contract and Trade Marked Name Use of SierraSil(R) in Its' Nutraceutical Formulations	2024-01-24
	PHBI - Phramagreen Targets Making Its Chibafreen Propriety Technology A Cannabis Industry Standard	2021-12-09
	PHBI - Pharmagreen Announces Revenue Plan For Proprietary Cannabis Tissue Culture Technology	2021-12-02
	Pharmagreen Biotech Inc. Announces the Formation of Independent Advisory Board	2019-09-03
	Pharmagreen Biotech Inc. selects Signify as its strategic technology partner and will be utilizing Philips LED Lighting technologies at its Cannabis Biotech Complex for its annual production of up to 12 million Tissue Culture Starter Plantlets for Cannabi	2019-07-23
	Pharmagreen Biotech Inc. Announces that Registration Statement on Form S-1 has been Declared Effective - Pharmagreen is a Cannabis Company that is a producer of highest quality CBD Hemp Plantlets	2019-07-18

10/Page

Articles on Neorich Biopharma Tech Co Ltd

No articles.

Headlines

No news.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.